Publications Repository

Publications Repository

View item 
  •   Home
  • ICR Divisions
  • Radiotherapy and Imaging
  • View item
  • Home
  • ICR Divisions
  • Radiotherapy and Imaging
  • View item
JavaScript is disabled for your browser. Some features of this site may not work without it.

Correlation between the radiation responses of fibroblasts cultured from individual patients and the risk of late reaction after breast radiotherapy.

Thumbnail
View/Open
Accepted version (2.643Mb)
Date
2016-05
ICR Author
Yarnold, John
Gothard, Lone
Somaiah, Navita
Author
Nuta, O
Somaiah, N
Boyle, S
Chua, MLK
Gothard, L
Yarnold, J
Rothkamm, K
Herskind, C
Show allShow less
Type
Journal Article
Metadata
Show full item record
Abstract
Late normal tissue toxicity varies widely between patients and limits breast radiotherapy dose. Here we aimed to determine its relationship to DNA damage responses of fibroblast cultures from individual patients. Thirty-five breast cancer patients, with minimal or marked breast changes after breast-conserving therapy consented to receive a 4 Gy test irradiation to a small skin field of the left buttock and have punch biopsies taken from irradiated and unirradiated skin. Early-passage fibroblast cultures were established by outgrowth and irradiated in vitro with 0 or 4 Gy. 53BP1 foci, p53 and p21/CDKN1A were detected by immunofluorescence microscopy. Residual 53BP1 foci counts 24 h after in vitro irradiation were significantly higher in fibroblasts from RT-sensitive versus RT-resistant patients. Furthermore, significantly larger fractions of p53- but not p21/CDKN1A-positive fibroblasts were found in cultures from RT-sensitive patients without in vitro irradiation, and 2 h and 6 d post-irradiation. Exploratory analysis showed a stronger p53 response 2 h after irradiation of fibroblasts established from patients with severe reaction. These results associate the radiation response of fibroblasts with late reaction of the breast after RT and suggest a correlation with severity.
URI
https://repository.icr.ac.uk/handle/internal/480
DOI
https://doi.org/10.1016/j.canlet.2016.02.036
Collections
  • Radiotherapy and Imaging
Subject
Cells, Cultured
Fibroblasts
Humans
Breast Neoplasms
Radiation Injuries
Microscopy, Fluorescence
Radiation Tolerance
Aged
Aged, 80 and over
Middle Aged
Female
Tumor Suppressor Protein p53
DNA Breaks, Double-Stranded
Randomized Controlled Trials as Topic
Research team
Translational Breast Radiobiology
Language
eng
Date accepted
2016-02-23
License start date
2016-05
Citation
Cancer letters, 2016, 374 (2), pp. 324 - 330

Browse

All of ICR repositoryICR DivisionsBy issue dateAuthorsTitlesPublication TypesThis collectionBy issue dateAuthorsTitlesPublication Types
  • Login
  • Registered office: The Institute of Cancer Research, 123 Old Brompton Road, London, SW7 3RP
    A Charity, Not for Profit. Company Limited by Guarantee.
    Registered in England No. 534147. VAT Registration No. GB 849 0581 02.